logo-loader
viewIGF Oncology

IGF Oncology looking to partner with pharma companies in 2020

IGF Oncology CEO Hugh McTavish sat down with Proactive Investors at the Biotech Showcase 2020 in San Francisco. The biotech company is developing targeted anti-cancer drugs in the blood cancer space, and recently revealed results from its clinical trials at the Mayo Clinic.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

1 day, 5 hours ago

2 min read